← Back to Search

Integrated Approach for Breast Cancer

N/A
Waitlist Available
Led By Cheryl L Holt, PhD
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Advisory Panel members: adults ages 21+
Pastors, representing each of the 14 churches enrolled in the project: active pastor of churches enrolled in the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 12 and 24 months
Awards & highlights

Study Summary

The proposed project will compare two ways to apply a known-effective cancer educational strategy through African American churches: 1) a standard method vs. 2) a new method in which the churches integrate the strategy into their organizational structure and practice at multiple levels. It will be determined whether this "integrated approach" results in more effective and sustained cancer education and screening activities at both the church and individual levels over time. This project will make important contributions to research in evidence-based medicine and sustainability. In a climate of limited resources, identifying sustainable and effective ways to increase cancer awareness and screening in African American men and women is more important than ever.

Eligible Conditions
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 12 and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 12 and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Integration of health-relation practices assessed via church survey
Secondary outcome measures
Adoption
Efficacy: Increased knowledge of cancer as assessment by participant surveys
Efficacy: Increased self-report of cancer screening as assessment by participant surveys
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Integrated ApproachExperimental Treatment1 Intervention
In this approach, rather than developing a separate health ministry, cancer activities could be integrated throughout existing church ministries (e.g. men's, women's, seniors).
Group II: Standard ComparisonActive Control1 Intervention
Standard group churches will not be asked to, or provided special encouragement to technical assistance with, institutionalizing health promotion activities in their churches.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Project HEAL 2.0
2016
N/A
~450

Find a Location

Who is running the clinical trial?

American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,011 Total Patients Enrolled
32 Trials studying Breast Cancer
8,438 Patients Enrolled for Breast Cancer
Community Ministry of Prince George's CountyUNKNOWN
University of Maryland, College ParkLead Sponsor
154 Previous Clinical Trials
45,039 Total Patients Enrolled
3 Trials studying Breast Cancer
162 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~51 spots leftby Mar 2025